Approval Alert | Pafolacianine for Ovarian Cancer Detection During Surgery

CancerNetwork® spoke with Phillip Low, PhD, about the development and FDA approval of pafolacianine.

Philip S. Low, PhD, discusses the obstacles he overcame while creating pafolacianine and what other cancers he hopes will be improved with the use of this agent.

Imaging drug pafolacianine was approved by the FDA to detect ovarian cancer lesions in patients during surgery.